My bookmarksSign up free

Commission Implementing Decision (EU) 2018/134 of 24 January 2018 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2018) 218) (Text with EEA relevance. )

Commission Implementing Decision (EU) 2018/134 of 24 January 2018 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2018) 218) (Text with EEA relevance. )

Implementing Decision (EU) 2018/134 · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Annexes I and II to Decision 2008/911/EC are amended in accordance with the Annex to this Decision.

Article 2

This Decision is addressed to the Member States.

Supplementary provisions

ANNEXSupplementary provisions

ANNEX Decision 2008/911/EC is amended as follows: (1) In Annex I, the following substance is inserted after Pimpinella anisum L: ‘ Sideritis scardica Griseb., herba.’; (2) In Annex II, the following is inserted after the COMMUNITY LIST ENTRY on Pimpinella anisum L: ‘UNION LIST ENTRY ON SIDERITIS SCARDIA GRISEB., HERBA Scientific name of the plant Sideritis scardica Griseb. Botanical family Lamiaceae (Labiatae) Herbal substance Ironwort ( Sideritis herba ) Common name in all EU official languages of herbal preparation BG (bălgarski): Мурсалски чай, стрък CS (čeština): nať hojníku DA (dansk): Kortkroneurt DE (Deutsch): Balkan-Gliedkraut EL (elliniká): Πόα σιδηρίτου EN (English): Ironwort ES (español): Siderita, partes aéreas de ET (eesti keel): haavarohuürt FI (suomi): raudakki, verso FR (français): Crapaudine (parties aériennes de) HR (hrvatska): očistova zelen HU (magyar): sármányvirág virágos hajtása IT (italiano): Stregonia parti aeree fiorite LT (lietuvių kalba): Timsrų žolė LV (latviešu valoda): Siderītu laksts MT (Malti): ħaxixa tas-Sideritis NL (Nederlands): (Griekse) bergthee, kruid PL (polski): Ziele gojnika PT (português): Siderite, partes aéreas RO (română): iarba de ceaiul muntelui cretan SK (slovenčina): Vňať ránhoja SL (slovenščina): zel sklepnjaka SV (svenska): Sårmynta, ört IS (íslenska): NO (norsk): Gresk fjellte Herbal preparations Comminuted herbal substance European Pharmacopoeia monograph reference Not applicable Indications Indication (1) Traditional herbal medicinal product used for the relief of cough associated with cold. Indication (2) Traditional herbal medicinal product used for the relief of mild gastrointestinal discomfort. The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use. Type of tradition European Specified strength Please see “Specified posology”. Specified posology Adults and elderly Indication (1) and (2) Single dose: Herbal tea: 2-4 g of the comminuted herbal substance in 150-200 ml of water as a herbal infusion 2-3 times daily Daily dose: up to 12 g The use in children and adolescents under 18 years of age is not recommended (see section “Special warnings and precautions for use”) Route of administration Oral use Duration of use or any restrictions on the duration of use Indication (1) If symptoms persist longer than 1 week during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Indication (2) If symptoms persist longer than 2 weeks during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Any other information necessary for the safe use Contraindications Hypersensitivity to the active substance and to other plants of the Lamiaceae (Labiatae) family. Special warnings and precautions for use The use in children and adolescents under 18 years of age has not been established due to lack of adequate data. If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Interactions with other medicinal products and other forms of interaction None reported Fertility, pregnancy and lactation Safety during pregnancy and lactation has not been established. In the absence of sufficient data, use during pregnancy and lactation is not recommended. No fertility data available. Effects on ability to drive and use machines No studies on the effect on the ability to drive and use machines have been performed. Undesirable effects None known If adverse reactions occur, a doctor or qualified health care practitioner should be consulted. Overdose No case of overdose has been reported. Pharmaceutical particulars (if necessary) Not applicable Pharmacological effects or efficacy plausible on the basis of long-standing use and experience (if necessary for the safe use of the product) Not applicable.’

Other acts of the same type
Council Decision (CFSP) 2026/1201 of 4 June 2026 amending Decision (CFSP) 2022/1093 on an assistance measure under the European Peace Facility to support the Armed Forces of the Republic of MoldovaCouncil Decision (CFSP) 2026/1202 of 4 June 2026 amending Decision (CFSP) 2023/921 on an assistance measure under the European Peace Facility to support the Armed Forces of the Republic of MoldovaCouncil Decision (CFSP) 2026/1218 of 4 June 2026 on an assistance measure under the European Peace Facility to support the Lebanese Armed ForcesCouncil Decision (CFSP) 2026/1222 of 4 June 2026 amending Decision (CFSP) 2023/1344 in support of enhancing the operational effectiveness of the Organisation for the Prohibition of Chemical Weapons (OPCW)Council Decision (CFSP) 2026/1223 of 4 June 2026 amending Decision (CFSP) 2024/1984 in support of the Institutional Transitional Planning for Non-Routine Missions and Investigative Capacities of the Organisation for the Prohibition of Chemical Weapons (OPCW)Commission Implementing Decision (EU) 2026/1239 of 4 June 2026 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States (notified under document C(2026) 3930)Council Implementing Decision (EU) 2026/1295 of 4 June 2026 authorising Sweden to apply reduced rates of excise duty to gas oil and unleaded petrol used as motor fuels, in accordance with Article 19 of Directive 2003/96/ECCouncil Decision (EU) 2026/1303 of 4 June 2026 on the position to be taken on behalf of the European Union at the 18th session of the Committee of Technical Experts of the Intergovernmental Organisation for International Carriage by Rail with regard to the revision of the Rules of Procedure of the Committee of Technical Experts, the revision of the Uniform Technical Prescriptions applicable to the subsystem ‘Rolling stock – freight wagons’ and to the subsystem ‘Rolling stock – locomotives and passenger rolling stock’, the adoption of a Uniform format of certificates and the amendment of the Uniform Technical Prescriptions applicable to the subsystem ‘Telematics applications for freight services’Council Decision (EU) 2026/1322 of 4 June 2026 on the position to be adopted on behalf of the European Union within the EEA Joint Committee concerning an amendment to Protocol 31 to the EEA Agreement, on cooperation in specific fields outside the four freedoms (Budget Line 07 20 03 01 – Social Security) (Text with EEA relevance)Council Decision (EU) 2026/1329 of 4 June 2026 authorising the opening of negotiations for sectoral agreements between the Union and Albania, Bosnia and Herzegovina, Kosovo, Montenegro, North Macedonia and Serbia, respectively, on roaming on public mobile communications networksCouncil Decision (EU) 2026/1340 of 4 June 2026 on the position to be taken on behalf of the European Union within the Technical Committees on Customs Valuation and on Rules of Origin established under the auspices of the World Customs Organization with regard to the adoption and preparation of advisory opinions, commentaries, explanatory notes, case studies, studies and similar instruments concerning the valuation of imported goods for customs purposes under the Agreement on Implementation of Article VII of the General Agreement on Tariffs and Trade 1994 and the adoption and preparation of advisory opinions, information and advice and similar instruments concerning the determination of the origin of goods under the Agreement on Rules of OriginCouncil Decision (EU) 2026/1347 of 4 June 2026 on the conclusion, on behalf of the European Union, of the United Nations Convention against Cybercrime; Strengthening International Cooperation for Combating Certain Crimes Committed by Means of Information and Communications Technology Systems and for the Sharing of Evidence in Electronic Form of Serious Crimes

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next